Press Release

Statement on Sec. Burwell's Delivery and Payment Reform

PhRMA January 26, 2015

Washington, D.C. (January 26, 2015) — Pharmaceutical Research and Manufacturers of America (PhRMA) president and chief executive officer John J. Castellani issued the following statement on Health and Human Services (HHS) Secretary Sylvia Mathews Burwell’s announcement on payment and delivery reform:


"PhRMA supports Secretary Burwell’s goal of advancing affordable, high quality and patient centered health care, and today’s announcement represents an important step forward.

“New medicines make important contributions to value in health care for patients, payers and policymakers, and we look forward to working with the secretary on this new initiative. As HHS works to evaluate and expand new models of health care payment and delivery, we believe it is essential they:

  1. Incorporate clear mechanisms for recognizing the value of new treatment advances, such as precision medicine and other new tests and treatments;

  2. Are grounded in strong quality measures and incentives, with emphasis on outcomes that matter to patients;

  3. Support shared decision making between providers and patients, which is informed by high quality evidence about the full range of available treatment options; and,

  4. Are transparent and enable manufacturers and other stakeholders to work collaboratively in support of high-quality, high-value health care.

“Reflecting our commitment to advancing sound, patient-centered payment models, PhRMA recently released

principles for payment and delivery system reform

. We appreciate the important announcement made today by Secretary Burwell, and look forward to continue working with HHS and other stakeholders on these important issues.”

PhRMA’s Principles for Payment and Delivery System Reforms can be found here:

About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $550 billion in the search for new treatments and cures, including an estimated $51.1 billion in 2013 alone. 

Find PhRMA Online: 

Website –

Facebook –

Blog –

Twitter –

YouTube –

For information on how innovative medicines save lives, visit:

For information on access to medicines, visit:

For information on the Partnership for Prescription Assistance, visit:

For information on ensuring the flow of medicines during public health emergencies, visit